日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice.

基质金属蛋白酶-9 缺乏症可使人类和小鼠的进行性骨化性纤维发育不良症具有抵抗力

Lounev Vitali, Groppe Jay C, Brewer Niambi, Wentworth Kelly L, Smith Victoria, Xu Meiqi, Schomburg Lutz, Bhargava Pankaj, Al Mukaddam Mona, Hsiao Edward C, Shore Eileen M, Pignolo Robert J, Kaplan Frederick S

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

替拉布替尼联合恩托斯普替尼(含或不含奥妥珠单抗)治疗复发性慢性淋巴细胞白血病的疗效和安全性

Kutsch, Nadine; Pallasch, Christian; Tausch, Eugen; Böhme, Volkmar; Ritgen, Matthias; Liersch, Rüdiger; Wacker, Alexander; Jacobs, Georg; Trappe, Ralf Ulrich; Dreger, Peter; Fischer, Kirsten; Fink, Anna-Maria; Stilgenbauer, Stephan; Zhai, Shuyan; Li, Biao; Jürgensmeier, Juliane M; Rajakumaraswamy, Nishanthan; Bhargava, Pankaj; Hallek, Michael; Eichhorst, Barbara F

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

替拉替尼和伊德拉利西布联合或不联合奥妥珠单抗治疗复发性慢性淋巴细胞白血病的疗效和安全性

Kutsch, Nadine; Pallasch, Christian; Decker, Thomas; Hebart, Holger; Chow, Kai Uwe; Graeven, Ullrich; Kisro, Jens; Kroeber, Alexander; Tausch, Eugen; Fischer, Kirsten; Fink, Anna-Maria; Wendtner, Clemens-Martin; Ritgen, Matthias; Stilgenbauer, Stephan; Zhang, Danjie; Li, Biao; Jürgensmeier, Juliane M; Rajakumaraswamy, Nishanthan; Bhargava, Pankaj; Hallek, Michael; Eichhorst, Barbara

Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)

评估安地卡利昔单抗联合 mFOLFOX6 作为一线治疗晚期胃癌或胃食管交界处腺癌患者的疗效和安全性的 III 期研究 (GAMMA-1)

Shah, Manish A; Bodoky, Gyorgy; Starodub, Alexander; Cunningham, David; Yip, Desmond; Wainberg, Zev A; Bendell, Johanna; Thai, Dung; He, Joyce; Bhargava, Pankaj; Ajani, Jaffer A

Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival

一项随机、开放标签的 II 期研究比较了安德卡利昔单抗联合纳武利尤单抗与单用纳武利尤单抗治疗晚期胃癌的疗效,并确定了与生存相关的生物标志物。

Shah, Manish A; Cunningham, David; Metges, Jean-Philippe; Van Cutsem, Eric; Wainberg, Zev; Elboudwarej, Emon; Lin, Kai-Wen; Turner, Scott; Zavodovskaya, Marianna; Inzunza, David; Liu, Jinfeng; Patterson, Scott D; Zhou, Jingzhu; He, Jing; Thai, Dung; Bhargava, Pankaj; Brachmann, Carrie Baker; Cantenacci, Daniel V T

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations

针对接受靶向治疗或化疗免疫疗法治疗的复发或难治性慢性淋巴细胞白血病患者的预后风险评分:一项回顾性汇总队列研究及外部验证

Soumerai, Jacob D; Ni, Ai; Darif, Mohamed; Londhe, Anil; Xing, Guan; Mun, Yong; Kay, Neil E; Shanafelt, Tait D; Rabe, Kari G; Byrd, John C; Chanan-Khan, Asher A; Furman, Richard R; Hillmen, Peter; Jones, Jeffrey; Seymour, John F; Sharman, Jeffrey P; Ferrante, Lucille; Mobasher, Mehrdad; Stark, Thomas; Reddy, Vijay; Dreiling, Lyndah K; Bhargava, Pankaj; Howes, Angela; James, Danelle F; Zelenetz, Andrew D

Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study.

西地尼布单药治疗晚期肝细胞癌的疗效、安全性、药代动力学和生物标志物:一项 II 期研究

Zhu Andrew X, Ancukiewicz Marek, Supko Jeffrey G, Sahani Dushyant V, Blaszkowsky Lawrence S, Meyerhardt Jeffrey A, Abrams Thomas A, McCleary Nadine Jackson, Bhargava Pankaj, Muzikansky Alona, Sheehan Susan, Regan Eileen, Vasudev Eamala, Knowles Michelle, Fuchs Charles S, Ryan David P, Jain Rakesh K, Duda Dan G

Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancer

一项针对难治性转移性结直肠癌患者的替沃扎尼(AV-951)联合依维莫司(RAD001)的多中心II期研究

Wolpin, Brian M; Ng, Kimmie; Zhu, Andrew X; Abrams, Thomas; Enzinger, Peter C; McCleary, Nadine J; Schrag, Deborah; Kwak, Eunice L; Allen, Jill N; Bhargava, Pankaj; Chan, Jennifer A; Goessling, Wolfram; Blaszkowsky, Lawrence S; Supko, Jeffrey G; Elliot, Meaghan; Sato, Kaori; Regan, Eileen; Meyerhardt, Jeffrey A; Fuchs, Charles S

Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors

贝伐珠单抗联合替莫唑胺治疗晚期神经内分泌肿瘤患者的前瞻性研究

Chan, Jennifer A; Stuart, Keith; Earle, Craig C; Clark, Jeffrey W; Bhargava, Pankaj; Miksad, Rebecca; Blaszkowsky, Lawrence; Enzinger, Peter C; Meyerhardt, Jeffrey A; Zheng, Hui; Fuchs, Charles S; Kulke, Matthew H

Development of second-generation VEGFR tyrosine kinase inhibitors: current status

第二代VEGFR酪氨酸激酶抑制剂的研发现状

Bhargava, Pankaj; Robinson, Murray O